These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 16094666

  • 1. Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.
    Wirth A, Yuen K, Barton M, Roos D, Gogna K, Pratt G, Macleod C, Bydder S, Morgan G, Christie D.
    Cancer; 2005 Sep 15; 104(6):1221-9. PubMed ID: 16094666
    [Abstract] [Full Text] [Related]

  • 2. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.
    Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.
    J Clin Oncol; 2010 Jan 01; 28(1):136-41. PubMed ID: 19933914
    [Abstract] [Full Text] [Related]

  • 3. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
    Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dörffel W, Wallace WH, Schellong G, Robert A, Körholz D, Oberlin O, Hall GW, Landman-Parker J.
    Cancer; 2007 Jul 01; 110(1):179-85. PubMed ID: 17526010
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
    Gocheva L, Koleva I.
    Klin Onkol; 2010 Jul 01; 23(1):34-42. PubMed ID: 20192072
    [Abstract] [Full Text] [Related]

  • 5. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.
    J Clin Oncol; 2006 Feb 01; 24(4):605-11. PubMed ID: 16446333
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
    Eich HT, Haverkamp U, Engert A, Kocher M, Skripnitchenko R, Brillant C, Sehlen S, Dühmke E, Diehl V, Müller RP.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):860-5. PubMed ID: 15925455
    [Abstract] [Full Text] [Related]

  • 8. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group.
    Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, Coiffier B, Bosly A, Diviné M, Brice P.
    Cancer; 2010 Feb 01; 116(3):631-9. PubMed ID: 20029973
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):839-46. PubMed ID: 15465201
    [Abstract] [Full Text] [Related]

  • 10. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 01; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
    Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP.
    Am J Clin Oncol; 2007 Dec 01; 30(6):601-6. PubMed ID: 18091054
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ, Rödel C, Gramatzki M, Niedobitek G, Sauer R, Grabenbauer GG.
    Strahlenther Onkol; 2003 Oct 01; 179(10):694-701. PubMed ID: 14566478
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A.
    J Clin Oncol; 2007 May 20; 25(15):2000-5. PubMed ID: 17420510
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.